MEMPHASYS LIMITED. - News & Media

Market Cap $13.00M Add to my watchlist

Memphasys Limited is an Australia-based reproductive biotechnology company. The Company... Memphasys Limited is an Australia-based reproductive biotechnology company. The Company is engaged in developing medical devices, diagnostics, and media with application to assisted reproductive technology (ART) in humans and animals. The Company's product pipeline includes Felix, RoXsta, and AI-Port. Its advanced product, the Felix System, is a patented automated device for quickly and gently separating sperm from a semen sample for use in ART procedures. The Felix device consists of two main components: a console, which supplies electrical power, and a sterile disposable cartridge for sperm isolation and selection. RoXsta is an in-vitro diagnostic device that assesses semen and other bodily fluids for oxidative stress load. RoXsta also has an application as part of a suite of products that can support the animal industry. AI-Port has been developed for the purpose of maintaining the viability of livestock semen for up to seven days at a temperature range of 22 - 25 degrees Celsius.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

No News & Media currently available.

(20min delay)
Last 0.5¢		Change -0.001(16.7%)		Mkt cap ! $13.00M

Open	High	Low	Value	Volume
0.5¢	0.5¢	0.5¢	$19.10K	3.821M

Buyers (Bids)

No.	Vol.	Price($)
11	4204169	0.5¢

Sellers (Offers)

Price($)	Vol.	No.
0.6¢	5374720	3

View Market Depth

No.	Vol.	Price($)
2	60206	0.024
1	14090	0.022
3	497619	0.021
5	649700	0.020
2	130000	0.018

Price($)	Vol.	No.
0.025	153799	6
0.037	18526	1
0.039	1200000	1
0.046	100000	1
0.047	1160000	3

Last trade - 15.56pm 07/11/2024 (20 minute delay)


Last 0.6¢		Change -0.001 ( 10.0 %)
Open	High	Low	Volume
0.5¢	0.6¢	0.5¢	1763959
Last updated 15.05pm 07/11/2024 ?

MEM (ASX) Chart